Scientists Question Safety of Merck’s New COVID “Wonder Drug” Expensive Molnupiravir is about to be authorized for millions of people based on a trial involving 500 patients

Posted by - October 13, 2021

Here we go again with another questionable new COVID drug developed with our tax dollars and sold back to us at massively inflated prices. First, there was the insanely expensive remdesivir and now there’s molnupiravir, an oral pill set to make Merck more billions. With splashy headlines, media outlets trumpeted molnupiravir, produced by Merck and Ridgeback

Read More